Sanofi Consumer Healthcare India Ltd. (SANOFICONR) 52 Week Low Streak Extends to Second Straight Session
- October 9, 2026
- Posted by: Kunal Singla
- Category: News
Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak has now extended to its second straight session, with the stock setting a fresh 52-week low again on 09 October 2026. Across the streak, the share price has fallen 4.67%, and the latest trough of Rs 3,551.60 matches the current traded level. Univest data confirms the repeated-low pattern, but it does not establish a company-specific cause for the continued decline.
The company’s market capitalisation stands at Rs 8,276.86 crore, so this Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak is being read in the context of a sizeable listed business rather than a one-day move alone. For readers, the more important signal is the repetition: back-to-back yearly lows usually deserve closer monitoring than a single-session break because they show a sustained deterioration in price over multiple sessions.
Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak: Consecutive Low Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 3,551.6 |
| Previous Close | Rs 3,593.85 |
| Today's Move | Rs -42.25 (-1.18%) |
| Open | Rs 3,594 |
| High | Rs 3,594 |
| Low | Rs 3,551.6 |
| Market Capitalisation | Rs 8,276.86 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) traded at Rs 3,551.6 versus the previous close of Rs 3,593.85, a fall of 1.18%. The stock opened at Rs 3,594, reached a high of Rs 3,594, touched a low of Rs 3,551.6.
At 09 October 2026 at 9:52 AM IST, Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak was still intact as the stock traded at Rs 3,551.60, down Rs 42.25 or 1.18% from the previous close of Rs 3,593.85. The session opened at Rs 3,594, reached a high of Rs 3,594 and slipped to a low of Rs 3,551.60, which also became the fresh 52-week low. The latest traded price sat at the day’s low, indicating that the stock was not recovering within the range during the snapshot.
That intraday placement matters because it shows the latest move was not just a brief dip below the prior close. The price stayed at the bottom of the range while the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak continued, and the market capitalisation of Rs 8,276.86 crore kept the decline anchored in a mid-sized consumer healthcare business. For this article type, the key point is not a single candle or one session, but the fact that the stock had already entered a repeated yearly-low pattern. The first break happened on the prior session, and the latest trade confirmed that the weakness extended into another day.
What the Repeated 52-Week Lows Show
The Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak is more important than the isolated day move because it shows the stock has kept revisiting lower ground across consecutive sessions. The cumulative decline of 4.67% across the streak is modest in absolute terms, but the repeated low itself is the stronger signal for readers tracking price behaviour. In practical terms, the stock has not merely slipped once; it has set a fresh yearly low on each of the last two sessions.
This kind of sequence tells investors that the latest low is not an outlier. The Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak also means the latest 52-week trough is now the reference point until a higher low is formed in future sessions. Since the latest Univest data does not establish a company-specific trigger, the responsible reading is simple: the pattern is confirmed, the cause is not.
For a reader watching Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, the focus should stay on whether the stock stabilises above the latest low or continues to print new yearly lows in the sessions ahead. That distinction matters more than comparing only the day’s percentage change.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 8,276.86 crore |
| P/E Ratio | 31.12x |
| P/B Ratio | 23.79x |
| ROE | 73.2% |
| ROCE | 98.11% |
| EPS | Rs 115.5 |
| Book Value Per Share | Rs 151.07 |
| Dividend Yield | 2.09% |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) fundamental metrics show P/E 31.12x, P/B 23.79x, ROE 73.2%, ROCE 98.11%. These ratios show where the company stands today and are not a call to buy or sell.
Sanofi Consumer Healthcare India Ltd. has a market capitalisation of Rs 8,276.86 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.12x, P/B at 23.79x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 73.2% and ROCE of 98.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 115.5, book value per share of Rs 151.07, dividend yield of 2.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.34x, median ROE of 11.53%, median ROCE of 13.32%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.12x |
| Benchmark Median P/E | 31.34x |
| Benchmark Average P/E | 47.18x |
| Benchmark P/E Range | 3.56x to 678.22x |
| Company P/B Ratio | 23.79x |
| Benchmark Median P/B | 2.83x |
| Company ROE | 73.2% |
| Benchmark Median ROE | 11.53% |
| Company ROCE | 98.11% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 8,276.86 crore |
| Benchmark Median Market Cap | Rs 803.77 crore |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 31.12x, which is below the benchmark median of 31.34x, a difference of -0.7%. A P/E difference of this kind is a reference point rather than a recommendation.
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROE of 73.2%, which is above the benchmark median of 11.53%, a difference of +534.87%. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a ROCE of 98.11%, which is above the benchmark median of 13.32%, a difference of +636.56%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Morepen Laboratories Ltd. | MOREPENLAB | 8,043.96 | 53.26 | 5.75 | 7.96 | 10.19 |
| Procter & Gamble Health Ltd. | PGHL | 8,561.21 | 23.99 | 13.91 | 62.18 | 84.86 |
| Aarti Pharmalabs Ltd. | AARTIPHARM | 8,644.96 | 37.41 | 3.64 | 8.5 | 10.77 |
| SYMBIOTEC PHARMALAB LTD | SYMBIOTEC | 7,267.04 | 63.98 | 4.69 | 11.22 | 12.41 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 7,208.67 | 52.41 | 5.79 | 12.11 | 17.4 |
Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a P/E ratio of 31.12x compared with the displayed peer median of 52.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 73.2% compares with a peer median of 11.22% across the companies shown in the table. ROCE stood at 98.11% versus the displayed peer median of 12.41%, providing a capital-efficiency comparison. Sanofi Consumer Healthcare India Ltd. (SANOFICONR) has a market capitalisation of Rs 8,276.86 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Sanofi Consumer Healthcare India Ltd.
- Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak has now run for two straight sessions, making the repeated low more relevant than a single-day break.
- The cumulative move across the streak is down 4.67%, which shows the decline has persisted beyond one trading day.
- The latest 52-week low of Rs 3,551.60 is now the key reference point for the next session.
- The stock still carries a P/E of 31.12 and a P/B of 23.79, so the valuation profile remains elevated versus the industry median on book value.
- Investors tracking Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak will want to watch whether the stock stabilises above the latest trough or prints another fresh yearly low.
About Sanofi Consumer Healthcare India Ltd.
Sanofi Consumer Healthcare India Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. For readers following the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, the relevant business context is that the company is still being assessed through its operating returns, valuation and listed market size rather than through a one-day trading story.
The company shows a market capitalisation of Rs 8,276.86 crore, EPS of Rs 115.5, book value of Rs 151.07, ROE of 73.2% and ROCE of 98.11. Those numbers help frame why the Sanofi Consumer Healthcare India Ltd. 52 Week Low StreakThat contrast is what investors usually need to keep in view when interpreting the stock’s current path.
Track Sanofi Consumer Healthcare India Ltd. Share Price on Univest
Use Sanofi Consumer Healthcare India Ltd. (SANOFICONR) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
The Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak is best followed session by session rather than read as a one-off event. Investors can track the latest price, market capitalisation and fresh low levels on the stock page to see whether the decline extends further or whether the stock starts building a higher reference point.
For now, the key takeaway is straightforward: the stock has already confirmed a repeated yearly-low pattern, and the next few sessions will show whether that pattern continues or pauses.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What does Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak mean?
Ans. It means the stock has set a fresh 52-week low on consecutive trading sessions. In this case, the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak has reached a second straight session, which is more significant than a single-day.
How many sessions has the stock stayed at a new 52-week low?
Ans. The stock has set a fresh 52-week low for two consecutive sessions.52 Week Low Streak on its second straight session.
By how much has the stock moved across the streak?
Ans. Across the streak, the stock is down 4.67%. That cumulative figure is the best way to read the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak because it captures the entire run, not just the latest session.
What is the latest 52-week low?
Ans. The latest 52-week low is Rs 3,551.60. That level also matches the current traded price in the latest snapshot, so the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak remains active at the same trough.
Does the data confirm why the stock kept falling?
Ans. No. The latest Univest data confirms the repeated low pattern, but it does not establish a company-specific cause. For the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, the pattern is confirmed and the reason is not.
How does the valuation look after the streak move?
Ans. The stock is at 31.12 times earnings and 23.79 times book value. The Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak has changed the price, but the reported earnings and book-value base remain the same in the latest Univest data.
How does the stock compare with its sector median?
Ans. The P/E is slightly below the industry median, while the P/B is far above it. That means the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak has not made the stock low-valued on book value versus the broader healthcare.
How does the stock compare with peers?
Ans. Against the listed peers, the stock’s P/E sits in the middle, while its P/B is the highest in the displayed group. The Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak therefore looks mixed on relative valuation.
What should investors monitor next?
Ans. Investors should watch whether the stock holds above Rs 3,551.60 or prints another fresh yearly low in the next session. For the Sanofi Consumer Healthcare India Ltd. 52 Week Low Streak, that next reference point is more important than the.
